Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ie-Ming Shih

Showing results (211-220 of 364) with videos related to

Pageof 37
Sort By:
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
Cancer Research|June 12, 2023
Temozolomide Sensitizes ARID1A-Mutated Cancers to PARP InhibitorsZheng-Cheng Yu, Tianhe Li, Ellen Tully, et al.
Genes & Diseases|September 26, 2022
Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)Jiaxin Hong, Yao-An Shen, Chih-Yi Hsu, et al.
The American Journal of Surgical Pathology|January 13, 2005
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlationGad Singer, Robert Stöhr, Leslie Cope, et al.
Cold Spring Harbor Molecular Case Studies|November 23, 2017
Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approachRen-Chin Wu, Ema Veras, Jeffrey Lin, et al.
Biochimica Et Biophysica Acta|August 9, 2005
Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinomaYu-Chi Chen, Ben Davidson, Chih-Chien Cheng, et al.
Journal of Visualized Experiments : Jove|March 6, 2023
Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in MiceRachel Vistein, Briana Winer, Stephanie Myers, et al.
American Journal of Obstetrics and Gynecology|October 23, 2010
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesisIe-Ming Shih, Li Chen, Chen C Wang, et al.
The American Journal of Surgical Pathology|September 5, 2014
BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumorsFelix Zeppernick, Laura Ardighieri, Charlotte G Hannibal, et al.
Plos One|May 9, 2012
Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sitesMichelle M Thiaville, Alexander Stoeck, Li Chen, et al.
Pageof 37

Showing results (211-220 of 364) with videos related to

Sort By:
Pageof 37
The Journal of Pathology|December 6, 2013
Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsLaura Ardighieri, Felix Zeppernick, Charlotte G Hannibal, et al.
Cancer Research|June 12, 2023
Temozolomide Sensitizes ARID1A-Mutated Cancers to PARP InhibitorsZheng-Cheng Yu, Tianhe Li, Ellen Tully, et al.
Genes & Diseases|September 26, 2022
Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC)Jiaxin Hong, Yao-An Shen, Chih-Yi Hsu, et al.
The American Journal of Surgical Pathology|January 13, 2005
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlationGad Singer, Robert Stöhr, Leslie Cope, et al.
Cold Spring Harbor Molecular Case Studies|November 23, 2017
Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approachRen-Chin Wu, Ema Veras, Jeffrey Lin, et al.
Biochimica Et Biophysica Acta|August 9, 2005
Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinomaYu-Chi Chen, Ben Davidson, Chih-Chien Cheng, et al.
Journal of Visualized Experiments : Jove|March 6, 2023
Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in MiceRachel Vistein, Briana Winer, Stephanie Myers, et al.
American Journal of Obstetrics and Gynecology|October 23, 2010
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesisIe-Ming Shih, Li Chen, Chen C Wang, et al.
The American Journal of Surgical Pathology|September 5, 2014
BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumorsFelix Zeppernick, Laura Ardighieri, Charlotte G Hannibal, et al.
Plos One|May 9, 2012
Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sitesMichelle M Thiaville, Alexander Stoeck, Li Chen, et al.
Pageof 37